This topic contains a solution. Click here to go to the answer

Author Question: Ethics laws prohibit a candidate or official from receiving a contribution inside A) a commercial ... (Read 40 times)

sdfghj

  • Hero Member
  • *****
  • Posts: 552
Ethics laws prohibit a candidate or official from receiving a contribution inside
 
  A) a commercial business building.
  B) a religious organization's building.
  C) the Democratic or Republican headquarters.
  D) the Texas state capitol building.

Question 2

Which congressional leadership position is mentioned in the U.S. Constitution?
 
  A) Speaker of the House
  B) majority leader of the House
  C) majority whip
  D) sergeant at arms
  E) secretary of state



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yahahah24021

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

D

Answer to Question 2

A




sdfghj

  • Member
  • Posts: 552
Reply 2 on: Jul 8, 2018
:D TYSM


komodo7

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library